You are currently viewing a new version of our website. To view the old version click .

35 Results Found

  • Article
  • Open Access
1 Citations
1,692 Views
23 Pages

Immunoreactivity Analysis of MHC-I Epitopes Derived from the Nucleocapsid Protein of SARS-CoV-2 via Computation and Vaccination

  • Dongbo Jiang,
  • Zilu Ma,
  • Junqi Zhang,
  • Yubo Sun,
  • Tianyuan Bai,
  • Ruibo Liu,
  • Yongkai Wang,
  • Liang Guan,
  • Shuaishuai Fu and
  • Yuanjie Sun
  • + 7 authors

25 October 2024

Background: Since 2019, the SARS-CoV-2 virus has been responsible for the global spread of respiratory illness. As of 1 September 2024, the cumulative number of infections worldwide exceeded 776 million. There are many structural proteins of the viru...

  • Article
  • Open Access
8 Citations
3,111 Views
20 Pages

In Silico Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes

  • Junqi Zhang,
  • Baozeng Sun,
  • Wenyang Shen,
  • Zhenjie Wang,
  • Yang Liu,
  • Yubo Sun,
  • Jiaxing Zhang,
  • Ruibo Liu,
  • Yongkai Wang and
  • Tianyuan Bai
  • + 8 authors

20 October 2023

(1) Background and Purpose: Ebola virus (EBOV) is the causative agent of Ebola virus disease (EVD), which causes extremely high mortality and widespread epidemics. The only glycoprotein (GP) on the surface of EBOV particles is the key to mediating vi...

  • Article
  • Open Access
2 Citations
4,535 Views
17 Pages

30 November 2022

Multiple vaccines were developed and administered to immunize people worldwide against SARS-CoV-2 infection. However, changes in platelet count following the course of vaccination have been reported by many studies, suggesting vaccine-induced thrombo...

  • Article
  • Open Access
2,829 Views
24 Pages

18 March 2024

The Marburg virus (MARV), the virus responsible for Marburg hemorrhagic fever (MHF), is considered a top-priority pathogen for vaccine development. Recent outbreaks in Equatorial Africa have highlighted the urgency of MARV because of its high fatalit...

  • Article
  • Open Access
1 Citations
1,666 Views
17 Pages

Application of Humanized MHC Transgenic Mice in the Screening of HLA–Restricted T Cell Epitopes for Influenza Vaccines

  • Yuwei Wei,
  • Keyu Sun,
  • Xuelian Han,
  • Yali Sun,
  • Jiejie Zhang,
  • Yuan Wang,
  • Qi Yin,
  • Tiantian Yang,
  • Kai Yuan and
  • Min Li
  • + 1 author

20 March 2025

Background: Annual influenza epidemics pose a significant burden on the global healthcare system. The currently available vaccines mainly induce the production of neutralizing antibodies against hemagglutinin and neuraminidase, which are prone to ant...

  • Article
  • Open Access
2 Citations
3,125 Views
19 Pages

AutoPepVax, a Novel Machine-Learning-Based Program for Vaccine Design: Application to a Pan-Cancer Vaccine Targeting EGFR Missense Mutations

  • Enrico Bautista,
  • Young Hyun Jung,
  • Manuela Jaramillo,
  • Harrish Ganesh,
  • Aryaan Varma,
  • Kush Savsani and
  • Sivanesan Dakshanamurthy

26 March 2024

The current epitope selection methods for peptide vaccines often rely on epitope binding affinity predictions, prompting the need for the development of more sophisticated in silico methods to determine immunologically relevant epitopes. Here, we dev...

  • Article
  • Open Access
17 Citations
6,537 Views
17 Pages

Measles Vaccines Designed for Enhanced CD8+ T Cell Activation

  • Elena Busch,
  • Kristina D. Kubon,
  • Johanna K. M. Mayer,
  • Gemma Pidelaserra-Martí,
  • Jessica Albert,
  • Birgit Hoyler,
  • Johannes P. W. Heidbuechel,
  • Kyle B. Stephenson,
  • Brian D. Lichty and
  • Wolfram Osen
  • + 4 authors

21 February 2020

Priming and activation of CD8+ T cell responses is crucial to achieve anti-viral and anti-tumor immunity. Live attenuated measles vaccine strains have been used successfully for immunization for decades and are currently investigated in trials of onc...

  • Article
  • Open Access
1 Citations
1,734 Views
16 Pages

Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma

  • Athanasios Seretis,
  • Lukas Amon,
  • Christoph H. Tripp,
  • Giuseppe Cappellano,
  • Florian Hornsteiner,
  • Sophie Dieckmann,
  • Janine Vierthaler,
  • Daniela Ortner-Tobider,
  • Markus Kanduth and
  • Rita Steindl
  • + 5 authors

25 March 2025

Background/Objectives: The revolution for the treatment of melanoma came with the approval of checkpoint blockade antibodies. However, a substantial proportion of patients show primary or secondary resistance to this type of immunotherapy, indicating...

  • Article
  • Open Access
20 Citations
8,274 Views
18 Pages

24 March 2015

Tumor vaccine design requires prediction and validation of immunogenic MHC class I epitopes expressed by target cells as well as MHC class II epitopes expressed by antigen-presenting cells essential for the induction of optimal immune responses. Epit...

  • Article
  • Open Access
3 Citations
3,122 Views
17 Pages

5 June 2021

Syngeneic murine systems have pre-fixed MHC, making them an imperfect model for investigating the impact of MHC polymorphism on immunodominance in influenza A virus (IAV) infections. To date, there are few studies focusing on MHC allelic differences...

  • Article
  • Open Access
9 Citations
3,273 Views
16 Pages

9 April 2024

Human papillomavirus type 16 (HPV16) infection is responsible for more than 50% of global cervical cancer cases. The development of a vaccine based on cytotoxic T-lymphocyte (CTL) epitopes is a promising strategy for eliminating pre-existing HPV infe...

  • Article
  • Open Access
14 Citations
3,582 Views
19 Pages

Background: After the start of the worldwide COVID-19 vaccination campaign, there were increased reports of autoimmune diseases occurring de novo after vaccination. This in silico analysis aimed to investigate the presence of protein epitopes encoded...

  • Article
  • Open Access
8 Citations
2,386 Views
21 Pages

Immunoinformatic Execution and Design of an Anti-Epstein–Barr Virus Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses

  • Naveed Ahmed,
  • Ali A. Rabaan,
  • Ameen S. S. Alwashmi,
  • Hawra Albayat,
  • Mutaib M. Mashraqi,
  • Ahmad A. Alshehri,
  • Mohammed Garout,
  • Wesam A. Abduljabbar,
  • Nik Yusnoraini Yusof and
  • Chan Yean Yean

One of the most important breakthroughs in healthcare is the development of vaccines. The life cycle and its gene expression in the numerous virus-associated disorders must be considered when choosing the target vaccine antigen for Epstein–Barr...

  • Article
  • Open Access
12 Citations
4,143 Views
25 Pages

Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes

  • Katharina Hartman,
  • Guido Steiner,
  • Michel Siegel,
  • Cary M. Looney,
  • Timothy P. Hickling,
  • Katharine Bray-French,
  • Sebastian Springer,
  • Céline Marban-Doran and
  • Axel Ducret

21 September 2023

A critical step in the immunogenicity cascade is attributed to human leukocyte antigen (HLA) II presentation triggering T cell immune responses. The liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based major histocompatibility comple...

  • Article
  • Open Access
10 Citations
5,755 Views
31 Pages

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana

  • Wonderful Tatenda Choga,
  • Motswedi Anderson,
  • Edward Zumbika,
  • Bonolo B. Phinius,
  • Tshepiso Mbangiwa,
  • Lynnette N. Bhebhe,
  • Kabo Baruti,
  • Peter Opiyo Kimathi,
  • Kaelo K. Seatla and
  • Rosemary M. Musonda
  • + 4 authors

6 July 2020

Hepatitis B virus (HBV) is the primary cause of liver-related malignancies worldwide, and there is no effective cure for chronic HBV infection (CHB) currently. Strong immunological responses induced by T cells are associated with HBV clearance during...

  • Article
  • Open Access
1 Citations
2,083 Views
16 Pages

VaccineDesigner: A Web-Based Tool for Streamlined Multi-Epitope Vaccine Design

  • Dimitrios Trygoniaris,
  • Anna Korda,
  • Anastasia Paraskeva,
  • Esmeralda Dushku,
  • Georgios Tzimagiorgis,
  • Minas Yiangou,
  • Charalampos Kotzamanidis and
  • Andigoni Malousi

7 August 2025

Background: Multi-epitope vaccines have become the preferred strategy for protection against infectious diseases by integrating multiple MHC-restricted T-cell and B-cell epitopes that elicit both humoral and cellular immune responses against pathogen...

  • Article
  • Open Access
24 Citations
3,697 Views
19 Pages

Immunoinformatics Approach to Design Multi-Epitope-Based Vaccine against Machupo Virus Taking Viral Nucleocapsid as a Potential Candidate

  • Muhammad Naveed,
  • Syeda Izma Makhdoom,
  • Urooj Ali,
  • Khizra Jabeen,
  • Tariq Aziz,
  • Ayaz Ali Khan,
  • Sumbal Jamil,
  • Muhammad Shahzad,
  • Metab Alharbi and
  • Abdulrahman Alshammari

17 October 2022

The family members of Arenaviridae include members of the genus Machupo virus, which have bi-segmented negative sense RNA inside the envelope and can be transferred to humans through rodent carriers. Machupo virus, a member of the mammarenavirus genu...

  • Review
  • Open Access
21 Citations
6,303 Views
28 Pages

Vaccine Vectors Harnessing the Power of Cytomegaloviruses

  • Mario Alberto Ynga-Durand,
  • Iryna Dekhtiarenko and
  • Luka Cicin-Sain

17 October 2019

Cytomegalovirus (CMV) species have been gaining attention as experimental vaccine vectors inducing cellular immune responses of unparalleled strength and protection. This review outline the strengths and the restrictions of CMV-based vectors, in ligh...

  • Article
  • Open Access
25 Citations
7,645 Views
32 Pages

Bioinformatics, Computational Informatics, and Modeling Approaches to the Design of mRNA COVID-19 Vaccine Candidates

  • Olugbenga Oluseun Oluwagbemi,
  • Elijah K. Oladipo,
  • Olatunji M. Kolawole,
  • Julius K. Oloke,
  • Temitope I. Adelusi,
  • Boluwatife A. Irewolede,
  • Emmanuel O. Dairo,
  • Ayodele E. Ayeni,
  • Kehinde T. Kolapo and
  • Olawumi E. Akindiya
  • + 3 authors

This article is devoted to applying bioinformatics and immunoinformatics approaches for the development of a multi-epitope mRNA vaccine against the spike glycoproteins of circulating SARS-CoV-2 variants in selected African countries. The study’s rele...

  • Article
  • Open Access
8 Citations
4,487 Views
18 Pages

A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse

  • Stacie Shiqi Wang,
  • Kylie Luong,
  • Fiona Margaret Gracey,
  • Shereen Jabar,
  • Brad McColl,
  • Ryan Stanley Cross and
  • Misty Rayna Jenkins

10 December 2021

Chimeric Antigen Receptor (CAR) T cell therapy is a promising form of adoptive cell therapy that re-engineers patient-derived T cells to express a hybrid receptor specific to a tumour-specific antigen of choice. Many well-characterised tumour antigen...

  • Article
  • Open Access
7 Citations
4,638 Views
18 Pages

Tolerance Induced by Antigen-Loaded PLG Nanoparticles Affects the Phenotype and Trafficking of Transgenic CD4+ and CD8+ T Cells

  • Tobias Neef,
  • Igal Ifergan,
  • Sara Beddow,
  • Pablo Penaloza-MacMaster,
  • Kathryn Haskins,
  • Lonnie D. Shea,
  • Joseph R. Podojil and
  • Stephen D. Miller

7 December 2021

We have shown that PLG nanoparticles loaded with peptide antigen can reduce disease in animal models of autoimmunity and in a phase 1/2a clinical trial in celiac patients. Clarifying the mechanisms by which antigen-loaded nanoparticles establish tole...

  • Article
  • Open Access
5 Citations
4,075 Views
10 Pages

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has posed a devastating threat worldwide. The receptor-binding domain (RBD) of the spike protein is one of the most important antigens for SARS-CoV-2 vaccines, while the analysis of CD8 cytotoxic T l...

  • Review
  • Open Access
40 Citations
7,648 Views
17 Pages

15 March 2023

Early efforts to identify tumor-associated antigens over the last decade have provided unique cancer epitopes for targeted cancer therapy. MAGE-A proteins are a subclass of cancer/testis (CT) antigens that are presented on the cell surface by MHC cla...

  • Review
  • Open Access
105 Citations
27,044 Views
20 Pages

29 October 2012

Lymphocytic choriomeningitis virus (LCMV) is a common infection of rodents first identified over eighty years ago in St. Louis, MO, U.S.A. It is best known for its application in immunological studies. The history of LCMV closely correlates with the...

  • Article
  • Open Access
4 Citations
3,606 Views
15 Pages

T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope

  • Mesha Saeed,
  • Erik Schooten,
  • Mandy van Brakel,
  • David K. Cole,
  • Timo L. M. ten Hagen and
  • Reno Debets

16 May 2020

Antibodies-recognising peptides bound to the major histocompatibility complex (pMHC) represent potentially valuable and promising targets for chimeric antigen receptor (CAR) T cells to treat patients with cancer. Here, a human phage-Fab library has b...

  • Article
  • Open Access
11 Citations
4,204 Views
16 Pages

Association of Porcine Swine Leukocyte Antigen (SLA) Haplotypes with B- and T-Cell Immune Response to Foot-and-Mouth Disease Virus (FMDV) Peptides

  • Patricia de León,
  • Rodrigo Cañas-Arranz,
  • Yago Saez,
  • Mar Forner,
  • Sira Defaus,
  • Dolores Cuadra,
  • María J. Bustos,
  • Elisa Torres,
  • David Andreu and
  • Esther Blanco
  • + 2 authors

8 September 2020

Dendrimer peptides are promising vaccine candidates against the foot-and-mouth disease virus (FMDV). Several B-cell epitope (B2T) dendrimers, harboring a major FMDV antigenic B-cell site in VP1 protein, are covalently linked to heterotypic T-cell epi...

  • Article
  • Open Access
6 Citations
3,044 Views
18 Pages

Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma

  • Yibin Liu,
  • Anna Keib,
  • Brigitte Neuber,
  • Lei Wang,
  • Angelika B. Riemer,
  • Maria Bonsack,
  • Angela Hückelhoven-Krauss,
  • Anita Schmitt,
  • Carsten Müller-Tidow and
  • Michael Schmitt

18 January 2023

The transcription factor SOX11 is a tumor-associated antigen with low expression in normal cells, but overexpression in glioblastoma (GBM). So far, conventional surgery, chemotherapy, and radiotherapy have not substantially improved the dismal progno...

  • Feature Paper
  • Article
  • Open Access
15 Citations
7,469 Views
15 Pages

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA

  • Diana Campillo-Davo,
  • Maarten Versteven,
  • Gils Roex,
  • Hans De Reu,
  • Sanne van der Heijden,
  • Sébastien Anguille,
  • Zwi N. Berneman,
  • Viggo F. I. Van Tendeloo and
  • Eva Lion

21 January 2020

The functional avidity of T-cell receptor (TCR)-engineered T cells towards their cognate epitope plays a crucial role in successfully targeting and killing tumor cells expressing the tumor-associated antigen (TAA). When evaluating in vitro functional...

  • Article
  • Open Access
6 Citations
5,376 Views
13 Pages

13 February 2018

While CD8+ memory T cells can promote long-lived protection from secondary exposure to intracellular pathogens, less is known regarding the direct protective mechanisms of CD4+ T cells. We utilized a prime/boost model in which mice are initially expo...

  • Article
  • Open Access
3 Citations
2,847 Views
21 Pages

18 September 2021

Preferred methods for generating mouse dendritic cells (DC) would encompass qualities of consistency, high yield, and potent function. Serum-free culture is also highly desirable, since this is the standard for cell-based therapies used in humans. We...

  • Article
  • Open Access
1 Citations
3,898 Views
13 Pages

Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized Mice

  • Christoph Schifflers,
  • Samantha Zottnick,
  • Jonas D. Förster,
  • Sebastian Kruse,
  • Ruwen Yang,
  • Hendrik Wiethoff,
  • Matthias Bozza,
  • Karin Hoppe-Seyler,
  • Mathias Heikenwälder and
  • Richard P. Harbottle
  • + 2 authors

25 January 2023

Head and neck squamous cell carcinomas (HNSCC) caused by infections with high-risk human papillomaviruses (HPV) are responsible for an increasing number of head and neck cancers, particularly in the oropharynx. Despite the significant biological diff...

  • Article
  • Open Access
4 Citations
4,594 Views
15 Pages

The CMV-Specific CD8+ T Cell Response Is Dominated by Supra-Public Clonotypes with High Generation Probabilities

  • Kilian Schober,
  • Pim Fuchs,
  • Jonas Mir,
  • Monika Hammel,
  • Lorenzo Fanchi,
  • Michael Flossdorf and
  • Dirk H. Busch

13 August 2020

Evolutionary processes govern the selection of T cell clonotypes that are optimally suited to mediate efficient antigen-specific immune responses against pathogens and tumors. While the theoretical diversity of T cell receptor (TCR) sequences is vast...

  • Article
  • Open Access
16 Citations
5,837 Views
13 Pages

Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model

  • Ling Wu,
  • Joanna Brzostek,
  • Shvetha Sankaran,
  • Qianru Wei,
  • Jiawei Yap,
  • Triscilla Y.Y. Tan,
  • Junyun Lai,
  • Paul A. MacAry and
  • Nicholas R. J. Gascoigne

18 February 2021

Chimeric antigen receptor T cells (CAR-T) utilize T cell receptor (TCR) signaling cascades and the recognition functions of antibodies. This allows T cells, normally restricted by the major histocompatibility complex (MHC), to be redirected to target...

  • Communication
  • Open Access
6 Citations
2,396 Views
9 Pages

The Induction of Antigen 85B-Specific CD8+ T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice

  • Shihoko Komine-Aizawa,
  • Satoru Mizuno,
  • Akira Kawano,
  • Satoshi Hayakawa,
  • Kazuhiro Matsuo and
  • Mitsuo Honda

Mycobacterium tuberculosis (Mtb) infection remains a major health problem worldwide. Although the Bacillus Calmette-Guérin (BCG) vaccine is the most widely used vaccination for preventing tuberculosis (TB), its efficacy is limited. We previous...

  • Article
  • Open Access
10 Citations
4,822 Views
20 Pages

CD4+ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help

  • Stephan Klessing,
  • Vladimir Temchura,
  • Pierre Tannig,
  • Antonia Sophia Peter,
  • Dennis Christensen,
  • Roland Lang and
  • Klaus Überla

13 October 2020

The induction of a potent and long-lasting, broadly neutralizing antibody response is one of the most promising approaches in HIV-1 vaccination. Recently, we demonstrated that Gag-specific T helper cells induced by DNA priming can enhance and modulat...